Literature DB >> 23051911

Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease.

Carola Seifried1, Sandra Boehncke, Jannika Heinzmann, Simon Baudrexel, Lutz Weise, Thomas Gasser, Karla Eggert, Wolfgang Fogel, Horst Baas, Klaus Badenhoop, Helmuth Steinmetz, Rüdiger Hilker.   

Abstract

BACKGROUND: Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality of life in patients with advanced Parkinson's disease (PD), but is associated with neuropsychiatric side effects and weight gain in some individuals. The pathomechanisms of these phenomena are still unknown. Considering anatomical and functional connections of the STN with the hypothalamic-pituitary (HP) system, we prospectively investigated whether chronic STN-DBS alters HP functioning in 11 PD patients.
METHODS: Basal hormone levels of the HP-adrenal (HPA), HP-gonadal and HP-somatotropic axis were determined before surgery as well as 3 and 6 months after electrode implantation. In addition, 24-hour cortisol profiles and dexamethasone suppression tests were obtained. Postoperative hormone changes were correlated with individual neuropsychological test performance, psychiatric status and anthropometric measures.
RESULTS: While PD patients experienced weight gain (p = 0.025) at follow-up, most neuropsychological data and basal HP hormone levels did not change over time. HPA regulation and diurnal rhythmicity of cortisol remained intact in all patients. The 24-hour mean cortisol levels decreased 6 months after surgery (p = 0.002) correlating with improved postoperative depression (p = 0.02).
CONCLUSIONS: Chronic application of high-frequency electrical stimuli in the STN was not associated with HP dysfunction in patients with advanced PD. The diurnal variability of peripheral cortisol secretion as one important element of the endogenous biological clock remained intact. Evening cortisol levels decreased after surgery reflecting a favorable regulation of the cortisol setpoint. STN-DBS can be considered safe from a neuroendocrine perspective, but the origin of unwanted side effects warrants further elucidation.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051911     DOI: 10.1159/000343808

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

Review 1.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

2.  Weight gain after subthalamic nucleus deep brain stimulation in Parkinson's disease is influenced by dyskinesias' reduction and electrodes' position.

Authors:  Roberta Balestrino; Damiano Baroncini; Mario Fichera; Carmine Antonio Donofrio; Alberto Franzin; Pietro Mortini; Giancarlo Comi; Maria Antonietta Volontè
Journal:  Neurol Sci       Date:  2017-09-14       Impact factor: 3.307

3.  Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons.

Authors:  Haichuan Wu; Xiang Yan; Dongliang Tang; Weixin Gu; Yiwen Luan; Haijiang Cai; Chunyi Zhou; Cheng Xiao
Journal:  Neurosci Bull       Date:  2020-06-21       Impact factor: 5.203

4.  Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Authors:  Nayron Medeiros Soares; Gabriela Magalhães Pereira; Vivian Altmann; Rosa Maria Martins de Almeida; Carlos R M Rieder
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

Review 5.  Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?

Authors:  Aleksandar Videnovic; Gregory L Willis
Journal:  Mov Disord       Date:  2016-01-30       Impact factor: 10.338

Review 6.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

7.  Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson's Disease.

Authors:  Ken Kuwahara; Tatsuya Sasaki; Takao Yasuhara; Masahiro Kameda; Yosuke Okazaki; Kakeru Hosomoto; Ittetsu Kin; Mihoko Okazaki; Satoru Yabuno; Satoshi Kawauchi; Yousuke Tomita; Michiari Umakoshi; Kyohei Kin; Jun Morimoto; Jea-Young Lee; Naoki Tajiri; Cesar V Borlongan; Isao Date
Journal:  Front Aging Neurosci       Date:  2020-06-16       Impact factor: 5.750

8.  Chronic deep brain stimulation of the hypothalamic nucleus in wistar rats alters circulatory levels of corticosterone and proinflammatory cytokines.

Authors:  Juan Manuel Calleja-Castillo; Dora Luz De La Cruz-Aguilera; Joaquín Manjarrez; Marco Antonio Velasco-Velázquez; Gabriel Morales-Espinoza; Julia Moreno-Aguilar; Maria Eugenia Hernández; Lucinda Aguirre-Cruz; Lenin Pavón
Journal:  Clin Dev Immunol       Date:  2013-10-23

Review 9.  Mechanisms of body weight fluctuations in Parkinson's disease.

Authors:  Andrea Kistner; Eugénie Lhommée; Paul Krack
Journal:  Front Neurol       Date:  2014-06-02       Impact factor: 4.003

Review 10.  Early Life Stress, Depression And Parkinson's Disease: A New Approach.

Authors:  Ernest Dallé; Musa V Mabandla
Journal:  Mol Brain       Date:  2018-03-19       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.